Dysregulation of cholesterol balance in the brain: contribution to neurodegenerative diseases

Gene Dose of Apolipoprotein E Type 4 Allele and the Risk of Alzheimer's Disease in Late Onset Families

Corder, E. H., Saunders, A. M., Strittmatter, W. J., Schmechel, D. E., Gaskell, P. C., Small, G. W., Roses, A. D., Haines, J. L., & Pericak-Vance, M. A. (1993) · Science · doi:10.1126/science.8346443 · Cited by 9,429 · see citing works

A Receptor-Mediated Pathway for Cholesterol Homeostasis

Brown, M. S., & Goldstein, J. L. (1986) · Science · doi:10.1126/science.3513311 · Cited by 5,703 · see citing works

Alzheimer's Disease Is a Synaptic Failure

Selkoe, D. J. (2002) · Science · doi:10.1126/science.1074069 · Cited by 4,420 · see citing works

Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease

Corder, E. H., Saunders, A. M., Risch, N. J., Strittmatter, W. J., Schmechel, D. E., Gaskell, P. C., Rimmler, J. B., Locke, P. A., Conneally, P. M., Schmader, K. E., et al. (1994) · Nature Genetics · doi:10.1038/ng0694-180 · Cited by 1,920 · see citing works

Statins and the risk of dementia

Jick, H., Zornberg, G. L., Jick, S. S., Seshadri, S. S., & Drachman, D. (2000) · The Lancet · doi:10.1016/s0140-6736(00)03155-x · Cited by 1,763 · see citing works

CNS synaptogenesis promoted by glia-derived cholesterol

Mauch, D. H., Nägler, K., Schumacher, S., Göritz, C., Müller, E.-C., Otto, A., & Pfrieger, F. W. (2001) · Science · doi:10.1126/science.294.5545.1354 · Cited by 1,711 · see citing works

Decreased Prevalence of Alzheimer Disease Associated With 3-Hydroxy-3-Methyglutaryl Coenzyme A Reductase Inhibitors

Wolozin, B. L. (2000) · Archives of Neurology · doi:10.1001/archneur.57.10.1439 · Cited by 1,401 · see citing works

Binding of human apolipoprotein E to synthetic amyloid beta peptide: isoform-specific effects and implications for late-onset Alzheimer disease.

Strittmatter, W. J., Weisgraber, K. H., Huang, D. Y., Dong, L. M., Salvesen, G. S., Pericak-Vance, M., Schmechel, D., Saunders, A. M., Goldgaber, D., & Roses, A. D. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.17.8098 · Cited by 1,363 · see citing works

Cholesterol Modification of Hedgehog Signaling Proteins in Animal Development

Porter, J. A., Young, K. E., & Beachy, P. A. (1996) · Science · doi:10.1126/science.274.5285.255 · Cited by 1,360 · see citing works

Human ApoE isoforms differentially regulate brain amyloid-β peptide clearance

Castellano, J. M., Kim, J., Stewart, F. R., Jiang, H., DeMattos, R. B., Patterson, B. W., Fagan, A. M., Morris, J. C., Mawuenyega, K. G., Cruchaga, C., et al. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3002156 · Cited by 1,227 · cited 12× · see citing works

Apolipoprotein E and its receptors in Alzheimer's disease: pathways, pathogenesis and therapy

Bu, G. (2009) · Nature Reviews Neuroscience · doi:10.1038/nrn2620 · Cited by 1,168 · see citing works

Cholesterol depletion inhibits the generation of β-amyloid in hippocampal neurons

Simons, M., Keller, P., Strooper, B. D., Beyreuther, K. T., Dotti, C. G., & Simons, K. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.11.6460 · Cited by 1,167 · see citing works

Amyloidogenic processing of the Alzheimer β-amyloid precursor protein depends on lipid rafts

Ehehalt, R., Keller, P., Haass, C., Thiele, C., & Simons, K. (2003) · The Journal of Cell Biology · doi:10.1083/jcb.200207113 · Cited by 1,107 · see citing works

Thematic review series: brain lipids. Cholesterol metabolism in the central nervous system during early development and in the mature animal

Dietschy, J. M., & Turley, S. D. (2004) · Journal of Lipid Research · doi:10.1194/jlr.r400004-jlr200 · Cited by 1,095 · see citing works

ApoE-Directed Therapeutics Rapidly Clear β-Amyloid and Reverse Deficits in AD Mouse Models

Cramer, P. E., Cirrito, J. R., Wesson, D. W., Lee, C. Y. D., Karlo, J. C., Zinn, A. E., Casali, B. T., Restivo, J. L., Goebel, W. D., James, M. J., et al. (2012) · Science · doi:10.1126/science.1217697 · Cited by 1,050 · see citing works

Differential loss of striatal projection neurons in Huntington disease.

Reiner, A. J., Albin, R. L., Anderson, K. D., D’Amato, C. J., Penney, J. B., & Young, A. B. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.15.5733 · Cited by 999 · see citing works

Cholesterol metabolism in the brain

Dietschy, J. M., & Turley, S. D. (2001) · Current Opinion in Lipidology · doi:10.1097/00041433-200104000-00003 · Cited by 906 · see citing works

Apolipoprotein E associated with astrocytic glia of the central nervous system and with nonmyelinating glia of the peripheral nervous system.

Boyles, J. K., Pitas, R. E., Wilson, E., Mahley, R. W., & Taylor, J. M. (1985) · Journal of Clinical Investigation · doi:10.1172/jci112130 · Cited by 829 · see citing works

Low cholesterol stimulates the nonamyloidogenic pathway by its effect on the α-secretase ADAM 10

Kojro, E., Gimpl, G., Lammich, S., März, W., & Fahrenholz, F. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.081612998 · Cited by 804 · see citing works

Differential Effects of Apolipoproteins E3 and E4 on Neuronal Growth in Vitro

Nathan, B. P., Bellosta, S., Sanan, D. A., Weisgraber, K. H., Mahley, R. W., & Pitas, R. E. (1994) · Science · doi:10.1126/science.8171342 · Cited by 795 · see citing works

A newly recognized syndromeof multiple congenital anomalies

Smith, D. W., Lemli, L., & Opitz, J. M. (1964) · The Journal of Pediatrics · doi:10.1016/s0022-3476(64)80264-x · Cited by 650 · see citing works

Niemann-Pick disease type C

Vanier, M., & Millat, G. (2003) · Clinical Genetics · doi:10.1034/j.1399-0004.2003.00147.x · Cited by 578 · see citing works

Apolipoprotein E promotes astrocyte colocalization and degradation of deposited amyloid-β peptides

Koistinaho, M., Lin, S., Wu, X., Esterman, M., Koger, D., Hanson, J., Higgs, R., Liu, F., Malkani, S., Bales, K. R., et al. (2004) · Nature Medicine · doi:10.1038/nm1058 · Cited by 571 · see citing works

Expression of apolipoprotein E during nerve degeneration and regeneration.

Ignatius, M. J., Gebicke‐Haerter, P. J., Skene, J. H. P., Schilling, J., Weisgraber, K. H., Mahley, R. W., & Shooter, E. M. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.4.1125 · Cited by 568 · see citing works

Switch-like Control of SREBP-2 Transport Triggered by Small Changes in ER Cholesterol: A Delicate Balance

Radhakrishnan, A., Goldstein, J. L., McDonald, J. G., & Brown, M. S. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2008.10.008 · Cited by 561 · see citing works

Induction of Alzheimer-like β-Amyloid Immunoreactivity in the Brains of Rabbits with Dietary Cholesterol

Sparks, D. L., Scheff, S. W., Hunsaker, J. C., Liu, H., Landers, T. M., & Gross, D. R. (1994) · Experimental Neurology · doi:10.1006/exnr.1994.1044 · Cited by 559 · see citing works

Clearing the brain's amyloid cobwebs

Selkoe, D. J. (2001) · Neuron · doi:10.1016/s0896-6273(01)00475-5 · Cited by 541 · see citing works

A role for apolipoprotein E, apolipoprotein A-I, and low density lipoprotein receptors in cholesterol transport during regeneration and remyelination of the rat sciatic nerve.

Boyles, J. K., Zoellner, C. D., Anderson, L. J., Kosik, L. M., Pitas, R. E., Weisgraber, K. H., Hui, D. Y., Mahley, R. W., Gebicke‐Haerter, P. J., & Ignatius, M. J. (1989) · Journal of Clinical Investigation · doi:10.1172/jci113943 · Cited by 533 · see citing works

ABCA1 is required for normal central nervous system ApoE levels and for lipidation of astrocyte-secreted apoE

Wahrle, S. E., Jiang, H., Parsadanian, M., Legleiter, J., Han, X., Fryer, J. D., Kowalewski, T., & Holtzman, D. M. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m407963200 · Cited by 474 · see citing works

Malformation syndromes caused by disorders of cholesterol synthesis

Porter, F. D., & Herman, G. E. (2011) · Journal of Lipid Research · doi:10.1194/jlr.r009548 · Cited by 473 · see citing works

The Amyloid Precursor Protein Has a Flexible Transmembrane Domain and Binds Cholesterol

Barrett, P. J., Song, Y., Horn, W. D. V., Hustedt, E. J., Schafer, J. M., Hadziselimovic, A., Beel, A. J., & Sanders, C. R. (2012) · Science · doi:10.1126/science.1219988 · Cited by 472 · see citing works

Cholesterol Modulates α-Secretase Cleavage of Amyloid Precursor Protein

Bodovitz, S., & Klein, W. L. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.8.4436 · Cited by 447 · see citing works

Wild-Type Huntingtin Protects from Apoptosis Upstream of Caspase-3

Rigamonti, D., Bauer, J. H., De‐Fraja, C., Conti, L., Sipione, S., Sciorati, C., Clementi, E., Hackam, A. S., Hayden, M. R., Li, Y., et al. (2000) · Journal of Neuroscience · doi:10.1523/jneurosci.20-10-03705.2000 · Cited by 406 · see citing works

Apolipoprotein E associates with beta amyloid peptide of Alzheimer's disease to form novel monofibrils. Isoform apoE4 associates more efficiently than apoE3

Sanan, D. A., Weisgraber, K. H., Russell, S. J., Mahley, R. W., Huang, D., Saunders, A., Schmechel, D., Wisniewski, T., Frangione, B., & Roses, A. D. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117407 · Cited by 404 · see citing works

Neurodegeneration in the Central Nervous System of apoE-Deficient Mice

Masliah, E., Mallory, M. E., Ge, N., Alford, M. F., Veinbergs, I., & Roses, A. D. (1995) · Experimental Neurology · doi:10.1006/exnr.1995.1088 · Cited by 402 · see citing works

Deficiency of ABCA1 Impairs Apolipoprotein E Metabolism in Brain

Hirsch-Reinshagen, V., Zhou, S., Burgess, B. L., Bernier, L., McIsaac, S. A., Chan, J. Y., Tansley, G. H., Cohn, J. S., Hayden, M. R., & Wellington, C. L. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m407962200 · Cited by 385 · see citing works

Reversal of defective lysosomal transport in NPC disease ameliorates liver dysfunction and neurodegeneration in the npc1 −/− mouse

Liu, B., Turley, S. D., Burns, D. K., Miller, A. M., Repa, J. J., & Dietschy, J. M. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0810895106 · Cited by 376 · see citing works

Overexpression of ABCA1 reduces amyloid deposition in the PDAPP mouse model of Alzheimer disease

Wahrle, S. E., Jiang, H., Parsadanian, M., Kim, J., Li, A., Knoten, A., Jain, S., Hirsch-Reinshagen, V., Wellington, C. L., Bales, K. R., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci33622 · Cited by 370 · cited 1× · see citing works

Blood—Brain Barrier Permeability Precedes Senile Plaque Formation in an Alzheimer Disease Model

UJIIE, M., DICKSTEIN, D. L., CARLOW, D. A., & JEFFERIES, W. A. (2003) · Microcirculation · doi:10.1038/sj.mn.7800212 · Cited by 351 · see citing works

Elevated levels of oxidized cholesterol metabolites in Lewy body disease brains accelerate α-synuclein fibrilization

Bosco, D. A., Fowler, D. M., Zhang, Q., Nieva, J. J., Powers, E. T., Wentworth, P., Lerner, R. A., & Kelly, J. W. (2006) · Nature Chemical Biology · doi:10.1038/nchembio782 · Cited by 349 · see citing works

A randomized, double-blind, placebo-controlled trial of simvastatin to treat Alzheimer disease

Sano, M., Bell, K. L., Galasko, D., Galvin, J. E., Thomas, R. G., van Dyck, C. H., & Aisen, P. S. S. (2011) · Neurology · doi:10.1212/wnl.0b013e318228bf11 · Cited by 336 · see citing works

Deletion of Abca1 Increases Aβ Deposition in the PDAPP Transgenic Mouse Model of Alzheimer Disease

Wahrle, S. E., Jiang, H., Parsadanian, M., Hartman, R. E., Bales, K. R., Paul, S. M., & Holtzman, D. M. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m508780200 · Cited by 325 · see citing works

Cholesterol 24-Hydroxylase: an enzyme of cholesterol turnover in the brain

Russell, D. W., Halford, R. W., Ramirez, D. M. O., Shah, R., & Kotti, T. (2009) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.78.072407.103859 · Cited by 317 · see citing works

The intracellular transport of low density lipoprotein-derived cholesterol is defective in Niemann-Pick type C fibroblasts.

Liscum, L., Ruggiero, R. M., & Faust, J. R. (1989) · The Journal of Cell Biology · doi:10.1083/jcb.108.5.1625 · Cited by 307 · see citing works

Marked differences in cholesterol synthesis between neurons and glial cells from postnatal rats

Nieweg, K., Schaller, H., & Pfrieger, F. W. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.05917.x · Cited by 307 · see citing works

Dysfunction of the Cholesterol Biosynthetic Pathway in Huntington's Disease

Valenza, M., Rigamonti, D., Goffredo, D., Zuccato, C., Fenu, S., Jamot, L., Strand, A., Tarditi, A., Woodman, B., Racchi, M., et al. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.3355-05.2005 · Cited by 298 · see citing works

Overexpression of Low-Density Lipoprotein Receptor in the Brain Markedly Inhibits Amyloid Deposition and Increases Extracellular Aβ Clearance

Kim, J., Castellano, J. M., Jiang, H., Basak, J. M., Parsadanian, M., Pham, V., Mason, S. M., Paul, S. M., & Holtzman, D. M. (2009) · Neuron · doi:10.1016/j.neuron.2009.11.013 · Cited by 274 · cited 2× · see citing works

Human<i>APOE</i>Isoform-Dependent Effects on Brain β-Amyloid Levels in PDAPP Transgenic Mice

Bales, K. R., Liu, F., Wu, S., Lin, S., Koger, D., DeLong, C., Hansen, J. C., Sullivan, P. M., & Paul, S. M. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.0887-09.2009 · Cited by 274 · see citing works

A sensitive and specific LC-MS/MS method for rapid diagnosis of Niemann-Pick C1 disease from human plasma

Jiang, X., Sidhu, R., Porter, F. D., Yanjanin, N. M., Speak, A. O., Vruchte, D. T., Platt, F. M., Fujiwara, H., Scherrer, D. E., Zhang, J., et al. (2011) · Journal of Lipid Research · doi:10.1194/jlr.d015735 · Cited by 270 · see citing works

Endocytosis of beta-cyclodextrins is responsible for cholesterol reduction in Niemann-Pick type C mutant cells

Rosenbaum, A. I., Zhang, G., Warren, J. D., & Maxfield, F. R. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0914309107 · Cited by 267 · see citing works

Apolipoprotein E exhibits isoform‐specific promotion of lipid efflux from astrocytes and neurons in culture

Michikawa, M., Fan, Q., Isobe, I., & Yanagisawa, K. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0741008.x · Cited by 244 · see citing works

The absence of ABCA1 decreases soluble ApoE levels but does not diminish amyloid deposition in two murine models of Alzheimer disease

Hirsch-Reinshagen, V., Maia, L. F., Burgess, B. L., Blain, J.-F., Naus, K. E., McIsaac, S. A., Parkinson, P. F., Chan, J. Y., Tansley, G. H., Hayden, M. R., et al. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m508781200 · Cited by 233 · see citing works

The LDL Receptor Gene Family

Herz, J. (2001) · Neuron · doi:10.1016/s0896-6273(01)00234-3 · Cited by 233 · see citing works

Patterned Purkinje cell degeneration in mouse models of Niemann‐Pick type C disease

Sarna, J. R., Larouche, M., Marzban, H., Sillitoe, R. V., Rancourt, D. E., & Hawkes, R. B. (2003) · The Journal of Comparative Neurology · doi:10.1002/cne.10522 · Cited by 223 · see citing works

Cholesterol Level and Statin Use in Alzheimer Disease

Shepardson, N. E. (2011) · Archives of Neurology · doi:10.1001/archneurol.2011.203 · Cited by 221 · see citing works

Update on Statins: 2003

Vaughan, C. J., & Gotto, A. M. (2004) · Circulation · doi:10.1161/01.cir.0000139312.10076.ba · Cited by 218 · see citing works

Identification of Surface Residues on Niemann-Pick C2 Essential for Hydrophobic Handoff of Cholesterol to NPC1 in Lysosomes

Wang, M. L., Motamed, M., Infante, R. E., Abi-Mosleh, L., Kwon, H. J., Brown, M. S., & Goldstein, J. L. (2010) · Cell Metabolism · doi:10.1016/j.cmet.2010.05.016 · Cited by 214 · see citing works

Oxysterols as biomarkers in neurodegenerative diseases

Leoni, V., & Caccia, C. (2011) · Chemistry and Physics of Lipids · doi:10.1016/j.chemphyslip.2011.04.002 · Cited by 212 · see citing works

Role of Lipoproteins in the Delivery of Lipids to Axons during Axonal Regeneration

de Chaves, E. I. P., Rusiñol, A. E., Vance, D. E., Campenot, R. B., & Vance, J. E. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.49.30766 · Cited by 209 · see citing works

ACAT1 gene ablation increases 24(S)-hydroxycholesterol content in the brain and ameliorates amyloid pathology in mice with AD

Bryleva, E. Y., Rogers, M. A., Chang, C. C. Y., Buen, F., Harris, B. T., Rousselet, E., Seidah, N. G., Oddo, S., LaFerla, F. M., Spencer, T. A., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0913828107 · Cited by 209 · see citing works

Total cholesterol and the risk of Parkinson disease

Hu, G., Antikaínen, R., Jousilahti, P., Kivipelto, M., & Tuomilehto, J. (2008) · Neurology · doi:10.1212/01.wnl.0000312511.62699.a8 · Cited by 205 · see citing works

Serum Cholesterol Levels and the Risk of Parkinson's Disease

de Lau, L. M. L., Koudstaal, P. J., Albert Hofman, D., & Breteler, M. M. B. (2006) · American Journal of Epidemiology · doi:10.1093/aje/kwj283 · Cited by 205 · see citing works

Adeno-associated Virus Gene Therapy With Cholesterol 24-Hydroxylase Reduces the Amyloid Pathology Before or After the Onset of Amyloid Plaques in Mouse Models of Alzheimer's Disease

Hudry, E., Dam, D. V., Kulik, W., Deyn, P. P. D., Stet, F. S., Ahouansou, O., Benraiss, A., Delacourte, A., Bougneres, P. F., Aubourg, P. R., et al. (2009) · Molecular Therapy · doi:10.1038/mt.2009.175 · Cited by 196 · see citing works

Glial Lipoproteins Stimulate Axon Growth of Central Nervous System Neurons in Compartmented Cultures

Hayashi, H., Campenot, R. B., Vance, D. E., & Vance, J. E. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m313828200 · Cited by 191 · see citing works

Lower low‐density lipoprotein cholesterol levels are associated with Parkinson's disease

Huang, X., Chen, H., Miller, W. C., Mailman, R. B., Woodard, J. L., Chen, P., Xiang, D., Murrow, R. W., Wang, Y., & Poole, C. (2006) · Movement Disorders · doi:10.1002/mds.21290 · Cited by 189 · see citing works

Cholesterol Level and Statin Use in Alzheimer Disease

Shepardson, N. E. (2011) · Archives of Neurology · doi:10.1001/archneurol.2011.242 · Cited by 181 · see citing works

Apolipoprotein E promotes β-amyloid trafficking and degradation by modulating microglial cholesterol levels

Lee, C. Y. D., Tse, W., Smith, J. D., & Landreth, G. E. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.295451 · Cited by 178 · see citing works

Formation and function of apolipoprotein E-containing lipoproteins in the nervous system

Vance, J. E., & Hayashi, H. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2010.02.007 · Cited by 178 · see citing works

Ontogenesis and regulation of cholesterol metabolism in the central nervous system of the mouse

Quan, G., Xie, C., Dietschy, J. M., & Turley, S. D. (2003) · Developmental Brain Research · doi:10.1016/j.devbrainres.2003.09.015 · Cited by 177 · see citing works

Postnatal development of inflammation in a murine model of Niemann–Pick type C disease: immunohistochemical observations of microglia and astroglia

Baudry, M., Yao, Y., Simmons, D. A., Liu, J., & Bi, X. (2003) · Experimental Neurology · doi:10.1016/s0014-4886(03)00345-5 · Cited by 174 · see citing works

Presenilin Redistribution Associated with Aberrant Cholesterol Transport Enhances β-Amyloid ProductionIn Vivo

Burns, M. P., Gaynor, K., Olm, V., Mercken, M. H., LaFrancois, J. J., Wang, L., Mathews, P. M., Noble, W. J., Matsuoka, Y., & Duff, K. (2003) · Journal of Neuroscience · doi:10.1523/jneurosci.23-13-05645.2003 · Cited by 172 · see citing works

Apolipoprotein E-Containing Lipoproteins Protect Neurons from Apoptosis via a Signaling Pathway Involving Low-Density Lipoprotein Receptor-Related Protein-1

Hayashi, H., Campenot, R. B., Vance, D. E., & Vance, J. E. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.5471-06.2007 · Cited by 170 · see citing works

Reducing Human Apolipoprotein E Levels Attenuates Age-Dependent Aβ Accumulation in Mutant Human Amyloid Precursor Protein Transgenic Mice

Bien-Ly, N., Gillespie, A. K., Walker, D., Yoon, S. Y., & Huang, Y. (2012) · The Journal of Neuroscience · doi:10.1523/jneurosci.0033-12.2012 · Cited by 170 · see citing works

Statins reduce neuronal α‐synuclein aggregation in in vitro models of Parkinson’s disease

Bar‐On, P., Crews, L. A., Koob, A. O., Mizuno, H., Adame, A., Spencer, B. J., & Masliah, E. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05254.x · Cited by 166 · see citing works

Cholesterol Defect Is Marked across Multiple Rodent Models of Huntington's Disease and Is Manifest in Astrocytes

Valenza, M., Leoni, V., Karasinska, J. M., Petricca, L., Fan, J., Carroll, J., Pouladi, M. A., Fossale, E., Nguyen, H. P., Riess, O., et al. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.0917-10.2010 · Cited by 166 · see citing works

Functions of lipoprotein receptors in neurons

Beffert, U., Stolt-Bergner, P. C., & Herz, J. (2004) · Journal of Lipid Research · doi:10.1194/jlr.r300017-jlr200 · Cited by 156 · see citing works

Oxysterols and Alzheimer's disease

Björkhem, I., Heverin, M., Leoni, V., Meaney, S., & Diczfalusy, U. (2006) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.2006.00684.x · Cited by 154 · see citing works

Cholesterol metabolism in Huntington disease

Karasinska, J. M., & Hayden, M. R. (2011) · Nature Reviews Neurology · doi:10.1038/nrneurol.2011.132 · Cited by 154 · see citing works

Unesterified Cholesterol Accumulation in Late Endosomes/Lysosomes Causes Neurodegeneration and Is Prevented by Driving Cholesterol Export from This Compartment

Aqul, A. A., Liu, B., Ramírez, C. M., Pieper, A. A., Estill, S. J., Burns, D. K., Liu, B., Repa, J. J., Turley, S. D., & Dietschy, J. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.1317-11.2011 · Cited by 152 · see citing works

Cholesterol accumulates in cell bodies, but is decreased in distal axons, of Niemann–Pick C1‐deficient neurons

Karten, B., Vance, D. E., Campenot, R. B., & Vance, J. E. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.01220.x · Cited by 149 · see citing works

Plasma apolipoprotein E and Alzheimer disease risk: The AIBL study of aging

Gupta, V. B., Laws, S. M., Villemagne, V. L., Ames, D., Bush, A. I., Ellis, K. A., Lui, J. K., Masters, C., Rowe, C. C., Szoeke, C., et al. (2011) · Neurology · doi:10.1212/wnl.0b013e318211c352 · Cited by 149 · see citing works

The fusogenic tilted peptide (67–78) of α-synuclein is a cholesterol binding domain

Fantini, J., Carlus, D., & Yahi, N. (2011) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2011.06.017 · Cited by 147 · see citing works

Severe learning deficits in apolipoprotein E-knockout mice in a water maze task

Oitzl, M. S., Mulder, M. T., Lucassen, P. J., Havekes, L. M., Grootendorst, J., & de Kloet, E. R. (1997) · Brain Research · doi:10.1016/s0006-8993(96)01448-5 · Cited by 142 · see citing works

The Low Density Lipoprotein Receptor Regulates the Level of CentralNervous System Human and Murine Apolipoprotein E but Does Not Modify AmyloidPlaque Pathology in PDAPPMice

Fryer, J. D., DeMattos, R. B., McCormick, L. M., O'Dell, M. A., Spinner, M. L., Bales, K. R., Paul, S. M., Sullivan, P. M., Parsadanian, M., Bu, G., et al. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m502143200 · Cited by 139 · see citing works

α-Synuclein Alters Notch-1 Expression and Neurogenesis in Mouse Embryonic Stem Cells and in the Hippocampus of Transgenic Mice

Crews, L. A., Mizuno, H., Desplats, P., Rockenstein, E. M., Adame, A., Patrick, C., Winner, B., Winkler, J., & Masliah, E. (2008) · Journal of Neuroscience · doi:10.1523/jneurosci.0066-08.2008 · Cited by 131 · see citing works

Effects of statins on human cerebral cholesterol metabolism and secretion of Alzheimer amyloid peptide

Fassbender, K. C., Stroick, M., Bertsch, T., Ragoschke, A., Kuehl, S., Walter, S., Walter, J., Brechtel-Curth, K., Muehlhauser, F., von Bergmann, K., et al. (2002) · Neurology · doi:10.1212/wnl.59.8.1257 · Cited by 119 · see citing works

Evidence for normal aging of the septo-hippocampal cholinergic system in apoE (−/−) mice but impaired clearance of axonal degeneration products following injury

Fagan, A. M., Murphy, B. A., Patel, S. N., Kilbridge, J. F., Mobley, W. C., Bu, G., & Holtzman, D. M. (1998) · Experimental Neurology · doi:10.1006/exnr.1998.6818 · Cited by 116 · see citing works

Cholesterol modification of proteins

Mann, R. K. (2000) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/s1388-1981(00)00148-7 · Cited by 113 · see citing works

Trafficking of Cholesterol from Cell Bodies to Distal Axons in Niemann Pick C1-deficient Neurons

Karten, B., Vance, D. E., Campenot, R. B., & Vance, J. E. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m205406200 · Cited by 106 · see citing works

Molecular mechanisms of Sonic hedgehog mutant effects in holoprosencephaly

Maity, T. K., Fuse, N., & Beachy, P. A. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0507848102 · Cited by 106 · see citing works

Uptake of lipoproteins for axonal growth of sympathetic neurons

Posse de Chaves, E. I., Vance, D. E., Campenot, R. B., Kiss, R. S., & Vance, J. E. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.26.19883 · Cited by 105 · see citing works

Anatomically Defined Neuron-Based Rescue of Neurodegenerative Niemann–Pick Type C Disorder

Lopez, M. E., Klein, A. D., Dimbil, U. J., & Scott, M. P. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.5981-10.2011 · Cited by 104 · see citing works

Marked accumulation of 27-hydroxycholesterol in the brains of Alzheimer's patients with the Swedish APP 670/671 mutation

Shafaati, M., Marutle, A., Pettersson, H. I., Lövgren‐Sandblom, A., Olin, M., Pikuleva, I. A., Winblad, B. G., Nordberg, A. K., & Björkhem, I. (2011) · Journal of Lipid Research · doi:10.1194/jlr.m014548 · Cited by 102 · see citing works

Normalization of Cholesterol Homeostasis by 2-Hydroxypropyl-β-cyclodextrin in Neurons and Glia from Niemann-Pick C1 (NPC1)-deficient Mice

Peake, K., & Vance, J. E. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.326405 · Cited by 96 · see citing works

Prospects of Statins in Parkinson Disease

Roy, A., & Pahan, K. (2011) · The Neuroscientist · doi:10.1177/1073858410385006 · Cited by 96 · see citing works

Cerebrotendinous xanthomatosis: An inborn error in bile acid synthesis with defined mutations but still a challenge

Björkhem, I., & Hansson, M. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.02.140 · Cited by 92 · see citing works

Cholesterol storage and tau pathology in Niemann–Pick type C disease in the brain

Distl, R., Treiber-Held, S., Albert, F., Meske, V., HARZER, K., & Ohm, T. G. (2003) · The Journal of Pathology · doi:10.1002/path.1320 · Cited by 91 · see citing works

β‐Site APP‐cleaving enzyme 1 trafficking and Alzheimer’s disease pathogenesis

Tan, J., & Evin, G. M. (2011) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2011.07623.x · Cited by 87 · see citing works

Nerve Regeneration Occurs in the Absence of Apolipoprotein E in Mice

Popko, B., Goodrum, J. F., Bouldin, T. W., Zhang, S. H., & Maeda, N. (1993) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1993.tb03268.x · Cited by 80 · see citing works

Hypercholesterolemia accelerates intraneuronal accumulation of Aβ oligomers resulting in memory impairment in Alzheimer's disease model mice

Umeda, T., Tomiyama, T., Kitajima, E., Idomoto, T., Nomura, S., Lambert, M. P., Klein, W. L., & Mori, H. (2012) · Life Sciences · doi:10.1016/j.lfs.2011.12.022 · Cited by 78 · see citing works

The role of APP proteolytic processing in lipid metabolism

Grimm, M. O. W., Rothhaar, T. L., & Hartmann, T. (2011) · Experimental Brain Research · doi:10.1007/s00221-011-2975-6 · Cited by 68 · see citing works

Update on statins

Schoor, J. V. (2008) · Pharmacy management · Cited by 65 · see citing works

Temporal and cell-specific deletion establishes that neuronal Npc1 deficiency is sufficient to mediate neurodegeneration

Yu, T., Shakkottai, V. G., Chung, C., & Lieberman, A. P. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr372 · Cited by 65 · see citing works

Links between ApoE, brain cholesterol metabolism, tau and amyloid β-peptide in patients with cognitive impairment

Leoni, V., Solomon, A., & Kivipelto, M. (2010) · Biochemical Society Transactions · doi:10.1042/bst0381021 · Cited by 65 · see citing works

Cholesterol metabolism, apolipoprotein E, adenosine triphosphate-binding cassette transporters, and Alzheimer's disease

Hirsch-Reinshagen, V., & Wellington, C. L. (2007) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e32813aeabf · Cited by 61 · see citing works

Inhibition of neuronal cholesterol biosynthesis with lovastatin leads to impaired synaptic vesicle release even in the presence of lipoproteins or geranylgeraniol

Mailman, T. M., Hariharan, M., & Karten, B. (2011) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2011.07474.x · Cited by 58 · see citing works

Protection of Neurons from Apoptosis by Apolipoprotein E-containing Lipoproteins Does Not Require Lipoprotein Uptake and Involves Activation of Phospholipase Cγ1 and Inhibition of Calcineurin

Hayashi, H., Campenot, R. B., Vance, D. E., & Vance, J. E. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.039560 · Cited by 58 · see citing works

The Niemann-Pick C1 protein in recycling endosomes of presynaptic nerve terminals

Karten, B., Campenot, R. B., Vance, D. E., & Vance, J. E. (2005) · Journal of Lipid Research · doi:10.1194/jlr.m500482-jlr200 · Cited by 53 · see citing works

Regulation of VLDL secretion in primary culture of rat hepatocytes: involvement of cAMP and cAMP‐dependent protein kinases

Björnsson, Ó. G., Sparks, J. D., Sparks, C. E., & Gibbons, G. F. (1994) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.1994.tb00979.x · Cited by 45 · see citing works

Generation and function of astroglial lipoproteins from Niemann–Pick type C1-deficient mice

Karten, B., Hayashi, H., Francis, G. A., Campenot, R. B., Vance, D. E., & Vance, J. E. (2005) · Biochemical Journal · doi:10.1042/bj20041694 · Cited by 43 · see citing works

Altered long-term potentiation in the hippocampus of apolipoprotein E-deficient mice

Veinbergs, I., Jung, M. W., Young, S. J., Uden, E. V., Groves, P. M., & Masliah, E. (1998) · Neuroscience Letters · doi:10.1016/s0304-3940(98)00399-1 · Cited by 42 · see citing works

Cholesterol precursors and facial clefting

Porter, F. D. (2006) · Journal of Clinical Investigation · doi:10.1172/jci29872 · Cited by 37 · see citing works

Crystal structure of amyloid precursor-like protein 1 and heparin complex suggests a dual role of heparin in E2 dimerization

Xue, Y., Lee, S., & Ha, Y. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1103407108 · Cited by 36 · see citing works

Pre‐synaptic defects of NPC1‐deficient hippocampal neurons are not directly related to plasma membrane cholesterol

Hawes, C. M., Wiemer, H., Krueger, S., & Karten, B. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.06768.x · Cited by 33 · see citing works

Transfer of Cholesterol by the NPC Team

Vance, J. E. (2010) · Cell Metabolism · doi:10.1016/j.cmet.2010.07.004 · Cited by 27 · see citing works

Elevated plasma cholesterol does not affect brain Aβ in mice lacking the low‐density lipoprotein receptor

Elder, G. A., Cho, J. Y., English, D. F., Franciosi, S., Schmeidler, J., Sosa, M. A. G., Gasperi, R. D., Fisher, E. A., Mathews, P. M., Haroutunian, V., et al. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04614.x · Cited by 26 · see citing works

Niemann-Pick Type C1 deficiency in microglia does not cause neuron death in vitro

Peake, K., Campenot, R. B., Vance, D. E., & Vance, J. E. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2011.06.003 · Cited by 24 · see citing works

Simvastatin and Other HMG-CoA Reductase Inhibitors on Brain Cholesterol Levels in Alzheimers Disease

Longenberger, J., & Shah, Z. A. (2011) · Current Alzheimer Research · doi:10.2174/156720511795745393 · Cited by 21 · see citing works

Lipoprotein receptors: beacons to neurons?

Herz, J. (2001) · Trends in Neurosciences · doi:10.1016/s0166-2236(00)01768-9 · Cited by 20 · see citing works

High levels of 15-oxygenated steroids in circulation of patients with multiple sclerosis: fact or fiction?

Björkhem, I., Lövgren‐Sandblom, A., Piehl, F., Khademi, M., Pettersson, H. I., Leoni, V., Olsson, T. P., & Diczfalusy, U. (2010) · Journal of Lipid Research · doi:10.1194/jlr.d011072 · Cited by 20 · see citing works

Brain lipidomics: From functional landscape to clinical significance

Yoon, J. H., Seo, Y., Jo, Y. S., Lee, S., Cho, E., Cazenave-Gassiot, A., Shin, Y.-S., Moon, M. H., An, H. J., Wenk, M. R., et al. (2022) · Science Advances · doi:10.1126/sciadv.adc9317 · Cited by 324 · see citing works

Cholesterol in brain disease: Sometimes determinant and frequently implicated

Martín, M. G., Pfrieger, F., & Dotti, C. G. (2014) · The EMBO Reports · doi:10.15252/embr.201439225 · Cited by 304 · see citing works

Oxysterols in the pathogenesis of major chronic diseases

Poli, G., Biasi, F., & Leonarduzzi, G. (2013) · Redox Biology · doi:10.1016/j.redox.2012.12.001 · Cited by 304 · see citing works

NPC1 regulates ER contacts with endocytic organelles to mediate cholesterol egress

Höglinger, D., Burgoyne, T., Sánchez-Heras, E., Hartwig, P., Colaço, A., Newton, J. C., Futter, C. E., Spiegel, S., Platt, F. M., & Eden, E. R. (2019) · Nature Communications · doi:10.1038/s41467-019-12152-2 · Cited by 280 · see citing works

Cholesterol catalyses Aβ42 aggregation through a heterogeneous nucleation pathway in the presence of lipid membranes

Habchi, J., Chia, S., Galvagnion, C., Michaels, T. C. T., Bellaiche, M. M. J., Ruggeri, F. S., Sanguanini, M., Idini, I., Kumita, J. R., Sparr, E., et al. (2018) · Nature Chemistry · doi:10.1038/s41557-018-0031-x · Cited by 245 · see citing works

Complex lipid trafficking in Niemann‐Pick disease type C

Vanier, M. T. (2014) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-014-9794-4 · Cited by 241 · see citing works

A suppressor screen in Mecp2 mutant mice implicates cholesterol metabolism in Rett syndrome

Buchovecky, C. M., Turley, S. D., Brown, H. M., Kyle, S. M., McDonald, J. G., Liu, B., Pieper, A. A., Huang, W., Katz, D. M., Russell, D. W., et al. (2013) · Nature Genetics · doi:10.1038/ng.2714 · Cited by 234 · see citing works

Heart disease as a risk factor for dementia

Hakim, A., Ng, & Turek (2013) · Clinical Epidemiology · doi:10.2147/clep.s30621 · Cited by 229 · see citing works

CYP46A1 inhibition, brain cholesterol accumulation and neurodegeneration pave the way for Alzheimer’s disease

Djelti, F., Braudeau, J., Hudry, E., Dhenain, M., Varin, J., Bièche, I., Marquer, C., Chali, F., Ayciriex, S., Auzeil, N., et al. (2015) · Brain · doi:10.1093/brain/awv166 · Cited by 223 · see citing works

Non-alcoholic fatty liver disease induces signs of Alzheimer’s disease (AD) in wild-type mice and accelerates pathological signs of AD in an AD model

Kim, D.-G., Krenz, A., Toussaint, L. E., Maurer, K. J., Robinson, S.-A., Yan, A., Torres, L., & Bynoe, M. S. (2016) · Journal of Neuroinflammation · doi:10.1186/s12974-015-0467-5 · Cited by 330 · see citing works

Brain Cholesterol Metabolism and Its Defects: Linkage to Neurodegenerative Diseases and Synaptic Dysfunction

Petrov, A. M., Kasimov, M. R., & Zefirov, A. L. (2016) · Acta Naturae · doi:10.32607/20758251-2016-8-1-58-73 · Cited by 194 · see citing works

Cholesterol Metabolism in Neurodegenerative Diseases: Molecular Mechanisms and Therapeutic Targets

Dai, L., Zou, L. B., Meng, L., Qiang, G., Yan, M., & Zhang, Z. (2021) · Molecular Neurobiology · doi:10.1007/s12035-020-02232-6 · Cited by 195 · see citing works

Pathogenesis of SCA3 and implications for other polyglutamine diseases

McLoughlin, H. S., Moore, L. R., & Paulson, H. L. (2019) · Neurobiology of Disease · doi:10.1016/j.nbd.2019.104635 · Cited by 185 · see citing works

Mitochondrial cholesterol: Metabolism and impact on redox biology and disease

Goicoechea, L., de la Rosa, L. C., Torres, S., García‐Ruiz, C., & Fernández-Checa, J. C. (2023) · Redox Biology · doi:10.1016/j.redox.2023.102643 · Cited by 183 · see citing works

ApoE Lipidation as a therapeutic target in Alzheimer’s disease

Lanfranco, M. F., Ng, C. A., & Rebeck, G. W. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21176336 · Cited by 189 · see citing works

Human physiomimetic model integrating microphysiological systems of the gut, liver, and brain for studies of neurodegenerative diseases

Trapecar, M., Wogram, E., Svoboda, D., Communal, C., Omer, A., Lungjangwa, T., Sphabmixay, P., Velazquez, J., Schneider, K., Wright, C. W., et al. (2021) · Science Advances · doi:10.1126/sciadv.abd1707 · Cited by 176 · see citing works

Targeting the mevalonate cascade as a new therapeutic approach in heart disease, cancer and pulmonary disease

Yeganeh, B., Wiecheć, E., Ande, S. R., Sharma, P. K., Moghadam, A. R., Post, M., Freed, D. H., Hashemi, M. M., Shojaei, S., Zeki, A. A., et al. (2014) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2014.02.007 · Cited by 172 · see citing works

Shared polygenic risk and causal inferences in amyotrophic lateral sclerosis

Bandrés‐Ciga, S., Noyce, A. J., Hemani, G., Nicolas, A., Calvo, A., Mora, G., Tienari, P., Stone, D. J., Nalls, M. A., Singleton, A., et al. (2019) · Annals of Neurology · doi:10.1002/ana.25431 · Cited by 162 · see citing works

Fatty Acid Signaling Mechanisms in Neural Cells: Fatty Acid Receptors

Falomir‐Lockhart, L. J., Cavazzutti, G. F., Giménez, E., & Toscani, A. M. (2019) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2019.00162 · Cited by 162 · see citing works

Intracellular Cholesterol Trafficking and Impact in Neurodegeneration

Arenas, F., García‐Ruiz, C., & Fernández-Checa, J. C. (2017) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2017.00382 · Cited by 161 · see citing works

Endogenous Allosteric Modulators of G Protein–Coupled Receptors

van der Westhuizen, E. T., Valant, C., Sexton, P. M., & Christopoulos, A. (2015) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.114.221606 · Cited by 144 · see citing works

Insulin action in the brain regulates both central and peripheral functions

Agrawal, R., Reno, C. M., Sharma, S., CHRISTENSEN, C. G., Huang, Y., & Fisher, S. J. (2021) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00642.2020 · Cited by 143 · see citing works

GM1 Ganglioside: Past Studies and Future Potential

Aureli, M., Mauri, L., Ciampa, M. G., Prinetti, A., Toffano, G., Secchieri, C., & Sonnino, S. (2015) · Molecular Neurobiology · doi:10.1007/s12035-015-9136-z · Cited by 140 · see citing works

Lipids in the nervous system: From biochemistry and molecular biology to patho-physiology

Cermenati, G., Mitro, N., Audano, M., Melcangi, R. C., Crestani, M., De Fabiani, E., & Caruso, D. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2014.08.011 · Cited by 137 · see citing works

Cerebral and extracerebral cholesterol metabolism and CSF markers of Alzheimer's disease.

Popp, J., Meichsner, S., Kölsch, H., Lewczuk, P., Maier, W., Kornhuber, J., Jessen, F., & Lütjohann, D. (2013) · Biochemical Pharmacology · doi:10.1016/j.bcp.2012.12.007 · Cited by 129 · see citing works

Massive transcriptome sequencing of human spinal cord tissues provides new insights into motor neuron degeneration in ALS

D’Erchia, A. M., Gallo, A., Manzari, C., Raho, S., Horner, D. S., Chiara, M., Valletti, A., Aiello, I., Mastropasqua, F., Ciaccia, L., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-10488-7 · Cited by 129 · see citing works

Linking mitochondrial dysfunction, metabolic syndrome and stress signaling in Neurodegeneration

Jha, S. K., Jha, N. K., Kumar, D., Ambasta, R. K., & Kumar, P. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2016.06.015 · Cited by 122 · see citing works

Statins and the Brain: More than Lipid Lowering Agents?

Fracassi, A., Marangoni, M., Rosso, P., Pallottini, V., Fioramonti, M., Siteni, S., & Segatto, M. (2018) · Current Neuropharmacology · doi:10.2174/1570159x15666170703101816 · Cited by 116 · see citing works

Apolipoprotein D

Rassart, É., Desmarais, F., Najyb, O., Bergeron, K., & Mounier, C. (2020) · Gene · doi:10.1016/j.gene.2020.144874 · Cited by 113 · see citing works

Use of LDL receptor—targeting peptide vectors for in vitro and in vivo cargo transport across the blood‐brain barrier

Molino, Y., David, M., Varini, K., Jabès, F., Gaudin, N., Fortoul, A., Bakloul, K., Masse, M., Bernard, A., Drobecq, L., et al. (2017) · The FASEB Journal · doi:10.1096/fj.201600827r · Cited by 112 · see citing works

Cholesterol-metabolizing enzyme cytochrome P450 46A1 as a pharmacologic target for Alzheimer's disease

Mast, N., Saadane, A., Valencia‐Olvera, A. C., Constans, J., Maxfield, E., Arakawa, H., Li, Y., Landreth, G. E., & Pikuleva, I. A. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.06.026 · Cited by 108 · see citing works

ApoE4-Induced Cholesterol Dysregulation and Its Brain Cell Type-Specific Implications in the Pathogenesis of Alzheimer's Disease.

Jeong, W., Lee, H. G., Cho, S., & Seo, J. (2019) · PubMed Central · doi:10.14348/molcells.2019.0200 · Cited by 104 · see citing works

Is Alzheimer's disease related to metabolic syndrome? A Wnt signaling conundrum

Ríos, J. A., Cisternas, P., Arrese, M. A., Salesa Barja, Y., & Inestrosa, N. C. (2014) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2014.07.004 · Cited by 104 · see citing works

APOE4-carrying human astrocytes oversupply cholesterol to promote neuronal lipid raft expansion and Aβ generation

Lee, S.-I., Jeong, W., Lim, H., Cho, S., Lee, H., Jang, Y., Cho, J., Bae, S., Lin, Y.-T., Tsai, L.-H., et al. (2021) · Stem Cell Reports · doi:10.1016/j.stemcr.2021.07.017 · Cited by 105 · see citing works

Cholesterol and metal ions in Alzheimer's disease

Lee, H. J., Korshavn, K. J., Kochi, A., Derrick, J. S., & Lim, M. H. (2014) · Chemical Society Reviews · doi:10.1039/c4cs00005f · Cited by 97 · see citing works

Lipids in regulating oligodendrocyte structure and function

Montani, L. (2020) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2020.07.016 · Cited by 94 · see citing works

Cholesterol homeostasis: Researching a dialogue between the brain and peripheral tissues

Gliozzi, M., Musolino, V., Bosco, F., Scicchitano, M., Scarano, F., Nucera, S., Zito, M. C., Ruga, S., Carresi, C., Macrì, R., et al. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.105215 · Cited by 92 · see citing works

Investigation of the prevalence of Cognitive Impairment and its risk factors within the elderly population in Shanghai, China

Ren, L., Zheng, Y., Wu, L., Gu, Y., He, Y., Jiang, B., Zhang, J., Zhang, L., & Li, J. (2018) · Scientific Reports · doi:10.1038/s41598-018-21983-w · Cited by 90 · see citing works

Therapeutic potential of targeting G protein-gated inwardly rectifying potassium (GIRK) channels in the central nervous system

Jeremic, D., Sanchez-Rodriguez, I., Jimenez-Diaz, L., & Navarro-Lopez, J. D. (2021) · Pharmacology &amp; Therapeutics · doi:10.1016/j.pharmthera.2021.107808 · Cited by 89 · see citing works

The LRRK2 G2019S mutation alters astrocyte-to-neuron communication via extracellular vesicles and induces neuron atrophy in a human iPSC-derived model of Parkinson’s disease

Jacquet, A. D. R., Tancredi, J. L., Lemire, A. L., DeSantis, M. C., Li, W., & O’Shea, E. K. (2021) · eLife · doi:10.7554/elife.73062 · Cited by 89 · see citing works

Lipoproteins in the Central Nervous System: From Biology to Pathobiology

Raulin, A.-C., Martens, Y. A., & Bu, G. (2022) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-032620-104801 · Cited by 89 · see citing works

Alternative mitochondrial electron transfer for the treatment of neurodegenerative diseases and cancers: Methylene blue connects the dots

Yang, S.-H., Li, W., Sumien, N., Forster, M. J., Simpkins, J. W., & Liu, R. (2015) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2015.10.005 · Cited by 86 · see citing works

Lipid Rafts in Neurodegeneration and Neuroprotection

Sonnino, S., Aureli, M., Grassi, S., Mauri, L., Prioni, S., & Prinetti, A. (2013) · Molecular Neurobiology · doi:10.1007/s12035-013-8614-4 · Cited by 85 · see citing works

Restoring brain cholesterol turnover improves autophagy and has therapeutic potential in mouse models of spinocerebellar ataxia

Nóbrega, C., Mendonça, L. S., Marcelo, A., Lamazière, A., Tomé, S. O., Després, G., Matos, C. A., Mechmet, F., Langui, D., den Dunnen, W. F. A., et al. (2019) · Acta Neuropathologica · doi:10.1007/s00401-019-02019-7 · Cited by 83 · see citing works

Cholesterol imbalance and neurotransmission defects in neurodegeneration

Shin, K. C., Moussa, H. Y. A., & Park, Y. (2024) · Experimental & Molecular Medicine · doi:10.1038/s12276-024-01273-4 · Cited by 81 · see citing works

Involvement of cholesterol in hepatitis B virus X protein-induced abnormal lipid metabolism of hepatoma cells via up-regulating miR-205-targeted ACSL4

Cui, M., Xiao, Z., Sun, B., Wang, Y., Zheng, M., Ye, L., & Zhang, X. (2014) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2014.02.068 · Cited by 78 · see citing works

A novel alkyne cholesterol to trace cellular cholesterol metabolism and localization

Hofmann, K., Thiele, C., Schött, H.-F., Gaebler, A., Schoene, M., Kiver, Y., Friedrichs, S., Litjohann, D., & Kuerschner, L. (2013) · Journal of Lipid Research · doi:10.1194/jlr.d044727 · Cited by 77 · see citing works

The beneficial effects of HMG-CoA reductase inhibitors in the processes of neurodegeneration

Saravi, S. S. S., Saravi, S. S. S., Arefidoust, A., & Dehpour, A. R. (2017) · Metabolic Brain Disease · doi:10.1007/s11011-017-0021-5 · Cited by 75 · see citing works

Statins—From Fungi to Pharmacy

Sadowska, A. J., Osiński, P., Roztocka, A., Kaczmarz-Chojnacka, K., Zapora, E., Sawicka, D., & Car, H. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms25010466 · Cited by 77 · see citing works

Brain Region Mapping Using Global Metabolomics

Ivanišević, J., Epstein, A. A., Kurczy, M. E., Benton, P., Uritboonthai, W., Fox, H. S., Boska, M. D., Gendelman, H. E., & Siuzdak, G. E. (2014) · Chemistry & Biology · doi:10.1016/j.chembiol.2014.09.016 · Cited by 74 · see citing works

Western Diet Induces Impairment of Liver-Brain Axis Accelerating Neuroinflammation and Amyloid Pathology in Alzheimer's Disease

Więckowska‐Gacek, A., Mietelska‐Porowska, A., Chutorański, D., Wydrych, M., Długosz, J., & Wojda, U. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.654509 · Cited by 69 · see citing works

Gangliosides in Membrane Organization

Sonnino, S., Chiricozzi, E., Grassi, S., Mauri, L., Prioni, S., & Prinetti, A. (2018) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2017.12.007 · Cited by 68 · see citing works

Overnutrition Determines LPS Regulation of Mycotoxin Induced Neurotoxicity in Neurodegenerative Diseases

Martins, I. J. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms161226190 · Cited by 67 · see citing works

microRNAs in Neurodegeneration: Current Findings and Potential Impacts

Sharma, S., & Lu, H. (2018) · Journal of Alzheimer’s Disease & Parkinsonism · doi:10.4172/2161-0460.1000420 · Cited by 66 · see citing works

Hippocampal Volume in Older Adults at Risk of Cognitive Decline: The Role of Sleep, Vascular Risk, and Depression

Elcombe, E. L., Lagopoulos, J., Duffy, S. L., Lewis, S. J. G., Norrie, L. M., Hickie, I. B., & Naismith, S. L. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-142016 · Cited by 65 · see citing works

Effects of oxysterols on the blood–brain barrier: Implications for Alzheimer’s disease

Gosselet, F., Saint‐Pol, J., & Fénart, L. (2013) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2013.11.059 · Cited by 61 · see citing works

Cholesterol – A putative endogenous contributor towards Parkinson's disease

Paul, R. K., Choudhury, A., & Borah, A. (2015) · Neurochemistry International · doi:10.1016/j.neuint.2015.07.025 · Cited by 61 · see citing works

Neuropsychiatric Adverse Events Associated with Statins: Epidemiology, Pathophysiology, Prevention and Management

Tuccori, M., Montagnani, S., Mantarro, S., Capogrosso-Sansone, A., Ruggiero, E., Saporiti, A., Antonioli, L., Fornai, M., & Blandizzi, C. (2014) · CNS Drugs · doi:10.1007/s40263-013-0135-1 · Cited by 58 · see citing works

Cholesterol in the Pathogenesis of Alzheimer’s, Parkinson’s Diseases and Autism: Link to Synaptic Dysfunction

Petrov, A. M., Kasimov, M. R., & Zefirov, A. L. (2017) · Acta Naturae · doi:10.32607/20758251-2017-9-1-26-37 · Cited by 56 · see citing works

The complexity of a monogenic neurodegenerative disease: More than two decades of therapeutic driven research into Niemann-Pick type C disease

Hammond, N., Munkacsi, A. B., & Sturley, S. L. (2019) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2019.04.002 · Cited by 57 · see citing works

The role of DHCR24 in the pathogenesis of AD: re-cognition of the relationship between cholesterol and AD pathogenesis

Bai, X., Mai, M., Yao, K., Zhang, M., Huang, Y. M., Zhang, W., Guo, X., Xu, Y., Zhang, Y., Qurban, A., et al. (2022) · Acta Neuropathologica Communications · doi:10.1186/s40478-022-01338-3 · Cited by 56 · see citing works

TRAP-seq Profiling and RNAi-Based Genetic Screens Identify Conserved Glial Genes Required for Adult Drosophila Behavior

Ng, F., Sengupta, S., Huang, Y., Yu, A. M., You, S., Roberts, M. A., Iyer, L. K., Yang, Y., & Jackson, F. R. (2016) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2016.00146 · Cited by 56 · see citing works

Cholesterol determines the cytosolic entry and seeded aggregation of tau

Tuck, B. J., Miller, L. V. C., Katsinelos, T., Smith, A. E., Wilson, E. L., Keeling, S., Cheng, S., Vaysburd, M. J., Knox, C., Tredgett, L., et al. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.110776 · Cited by 56 · see citing works

Myelin Pathology in Alzheimer's Disease: Potential Therapeutic Opportunities

Huang, Z., Jordan, J. D., & Zhang, Q. (2023) · Aging and Disease · doi:10.14336/ad.2023.0628 · Cited by 54 · see citing works

Astrocytes and endoplasmic reticulum stress: A bridge between obesity and neurodegenerative diseases

Martín-Jiménez, C., García-Vega, Á. S., Cabezas, R., Aliev, G., Echeverrı́a, V., González, J., & Barreto, G. E. (2017) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2017.08.001 · Cited by 55 · see citing works

Structural insights into GIRK2 channel modulation by cholesterol and PIP2

Mathiharan, Y. K., Glaaser, I. W., Zhao, Y., Robertson, M. J., Skiniotis, G., & Slesinger, P. A. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.109619 · Cited by 52 · see citing works

Role of Trisomy 21 Mosaicism in Sporadic and Familial Alzheimer's Disease

Potter, H., Granic, A., & Caneus, J. (2015) · Current Alzheimer Research · doi:10.2174/156720501301151207100616 · Cited by 53 · see citing works

Hypertension, cerebrovascular impairment, and cognitive decline in aged AβPP/PS1 mice

Wiesmann, M., Zerbi, V., Jansen, D., Lütjohann, D., Veltien, A. A., Heerschap, A., & Kiliaan, A. J. (2017) · Theranostics · doi:10.7150/thno.18509 · Cited by 52 · see citing works

Cytochrome P450 in the central nervous system as a therapeutic target in neurodegenerative diseases

Navarro‐Mabarak, C., Camacho‐Carranza, R., & Espinosa-Aguirre, J. J. (2018) · Drug Metabolism Reviews · doi:10.1080/03602532.2018.1439502 · Cited by 53 · see citing works

Brain‐derived neurotrophic factor modulates cholesterol homeostasis and Apolipoprotein E synthesis in human cell models of astrocytes and neurons

Spagnuolo, M. S., Donizetti, A., Iannotta, L., Aliperti, V., Cupidi, C., Bruni, A. C., & Cigliano, L. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.26480 · Cited by 52 · see citing works

Relationship between high dietary fat intake and Parkinson’s disease risk: a meta-analysis

Sun, Q., Qu, Y., Chen, X., & Xu, M. (2019) · Neural Regeneration Research · doi:10.4103/1673-5374.262599 · Cited by 51 · see citing works

Transcriptional analysis of peripheral memory T cells reveals Parkinson’s disease-specific gene signatures

Dhanwani, R., Lima-Júnior, J. R., Sethi, A., Pham, J. W., Williams, G. P., Frazier, A., Xu, Y., Amara, A. W., Standaert, D. G., Goldman, J. G., et al. (2022) · npj Parkinson s Disease · doi:10.1038/s41531-022-00282-2 · Cited by 51 · see citing works

Pharmacogenetic Considerations in the Treatment of Alzheimer’s Disease

Cacabelos, R., Torrellas, C., Teijido, Ó., & Carril, J. C. (2016) · Pharmacogenomics · doi:10.2217/pgs-2016-0031 · Cited by 50 · see citing works

Linking phytosterols and oxyphytosterols from food to brain health: origins, effects, and underlying mechanisms

Jie, F., Yang, X., Wu, L., Wang, M., & Lu, B. (2021) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2020.1867819 · Cited by 50 · see citing works

microRNAs: A connection between cholesterol metabolism and neurodegeneration

Goedeke, L., & Fernandez-Hernando, C. F. (2014) · Neurobiology of Disease · doi:10.1016/j.nbd.2014.05.034 · Cited by 49 · see citing works

Universal phase behaviors of intracellular lipid droplets

Shimobayashi, S. F., & Ohsaki, Y. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1916248116 · Cited by 49 · see citing works

Implications of cerebrovascular ATP-binding cassette transporter G1 (ABCG1) and apolipoprotein M in cholesterol transport at the blood-brain barrier

Kober, A. C., Manavalan, A. P. C., Tam‐Amersdorfer, C., Holmér, A., Saeed, A., Fanaee‐Danesh, E., Zandl‐Lang, M., Albrecher, N. M., Björkhem, I., Kostner, G. M., et al. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2017.03.003 · Cited by 47 · see citing works

Dual activation of neuronal G protein-gated inwardly rectifying potassium (GIRK) channels by cholesterol and alcohol

Glaaser, I. W., & Slesinger, P. A. (2017) · Scientific Reports · doi:10.1038/s41598-017-04681-x · Cited by 45 · see citing works

Neuroprotective effects of statins against amyloid β-induced neurotoxicity

Huang, C., Li, H., & Lin, C. (2018) · Neural Regeneration Research · doi:10.4103/1673-5374.226379 · Cited by 47 · see citing works

Quercetin inhibition of SREBPs and ChREBP expression results in reduced cholesterol and fatty acid synthesis in C6 glioma cells

Damiano, F., Giannotti, L., Gnoni, G. V., Siculella, L., & Gnoni, A. (2019) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2019.105618 · Cited by 44 · see citing works

Simvastatin treatment exerts antidepressant-like effect in rats exposed to chronic mild stress

Lin, P.-Y., Chang, A. Y. W., & Lin, T.-K. (2014) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2014.06.006 · Cited by 43 · see citing works

Astrocytic Factors Controlling Synaptogenesis: A Team Play

Fossati, G., Matteoli, M., & Menna, E. (2020) · Cells · doi:10.3390/cells9102173 · Cited by 44 · see citing works

Disease-associated mutations in Niemann-Pick type C1 alter ER calcium signaling and neuronal plasticity

Tiscione, S. A., Vivas, O., Ginsburg, K. S., Bers, D. M., Ory, D. S., Santana, L. F., Dixon, R. E., & Dickson, E. J. (2019) · The Journal of Cell Biology · doi:10.1083/jcb.201903018 · Cited by 43 · see citing works

Dietary cholesterol, fats and risk of Parkinson's disease in the Singapore Chinese Health Study

Tan, L., Methawasin, K., Tan, E., Tan, J. H., Au, W., Yuan, J., & Koh, W. (2015) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2014-310065 · Cited by 42 · see citing works

Resveratrol Intervenes Cholesterol- and Isoprenoid-Mediated Amyloidogenic Processing of AβPP in Familial Alzheimer’s Disease

Sathya, M., Ponnusamy, M., Palanisamy, P., Kandasamy, M., Jayachandran, K. S., & Anusuyadevi, M. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-161034 · Cited by 41 · see citing works

Super‐Resolution Microscopy Using a Bioorthogonal‐Based Cholesterol Probe Provides Unprecedented Capabilities for Imaging Nanoscale Lipid Heterogeneity in Living Cells

Lorizate, M., Terrones, O., Nieto‐Garai, J. A., Rojo‐Bartolomé, I., Ciceri, D., Morana, O., Olazar‐Intxausti, J., Arboleya, A., Martin, A., Szynkiewicz, M., et al. (2021) · Small Methods · doi:10.1002/smtd.202100430 · Cited by 40 · see citing works

Repeated Administration of 2-Hydroxypropyl-β-Cyclodextrin (HPβCD) Attenuates the Chronic Inflammatory Response to Experimental Stroke

Becktel, D. A., Zbesko, J. C., Frye, J. B., Chung, A. G., Hayes, M., Calderon, K., Grover, J. W., Li, A., Garcia, F. G., Tavera-Garcia, M. A., et al. (2021) · Journal of Neuroscience · doi:10.1523/jneurosci.0933-21.2021 · Cited by 40 · see citing works

Visualization of accessible cholesterol using a GRAM domain-based biosensor

Koh, D. H. Z., Naito, T., Na, M., Yeap, Y. J., Rozario, P., Zhong, F. L., Lim, K., & Saheki, Y. (2023) · Nature Communications · doi:10.1038/s41467-023-42498-7 · Cited by 40 · see citing works

Mitotic Spindle Defects and Chromosome Mis-Segregation Induced by LDL/Cholesterol—Implications for Niemann-Pick C1, Alzheimer’s Disease, and Atherosclerosis

Granic, A., & Potter, H. (2013) · PLoS ONE · doi:10.1371/journal.pone.0060718 · Cited by 40 · see citing works

In vivo antioxidative and neuroprotective effect of 4-Allyl-2-methoxyphenol against chlorpyrifos-induced neurotoxicity in rat brain

Singh, V. M., & Panwar, R. (2013) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-013-1899-9 · Cited by 40 · see citing works

The Impact of Lipoproteins on Wound Healing: Topical HDL Therapy Corrects Delayed Wound Healing in Apolipoprotein E Deficient Mice

Gordts, S. C., Muthuramu, I., Amin, R., Jacobs, F., & Geest, B. D. (2014) · Pharmaceuticals · doi:10.3390/ph7040419 · Cited by 39 · see citing works

Amyloid beta increases ABCA1 and HMGCR protein expression, and cholesterol synthesis and accumulation in mice neurons and astrocytes

Azizidoost, S., Babaahmadi‐Rezaei, H., Nazeri, Z., Cheraghzadeh, M., & Kheirollah, A. (2021) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2021.159069 · Cited by 39 · see citing works

Aging Induces Tissue‐Specific Changes in Cholesterol Metabolism in Rat Brain and Liver

Smiljanić, K., Vanmierlo, T., Mladenović, A., Perović, M., Lončarević‐Vasiljković, N., Tešić, V., Rakić, L., Ruždijić, S., Lütjohann, D., & Kanazir, S. (2013) · Lipids · doi:10.1007/s11745-013-3836-9 · Cited by 39 · see citing works

Brain cholesterol homeostasis and its association with neurodegenerative diseases

Gao, Y., Ye, S., Tang, Y., Tong, W., & Sun, S. (2023) · Neurochemistry International · doi:10.1016/j.neuint.2023.105635 · Cited by 38 · see citing works

Oral administration of repurposed drug targeting Cyp46A1 increases survival times of prion infected mice

Ali, T., Hannaoui, S., Nemani, S. K., Tahir, W., Zemlyankina, I., Cherry, P., Shim, S. Y., Sim, V. L., Schaetzl, H. M., & Gilch, S. (2021) · Acta Neuropathologica Communications · doi:10.1186/s40478-021-01162-1 · Cited by 38 · see citing works

Gender-specific prevalence and risk factors of mild cognitive impairment among older adults in Chongming, Shanghai, China

Liu, Y., Yu, X., Han, P., Chen, X., Wang, F., Lian, X., Li, J., Li, R., Wang, B., Xu, C., et al. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.900523 · Cited by 38 · see citing works

FXR-Mediated Cortical Cholesterol Accumulation Contributes to the Pathogenesis of Type A Hepatic Encephalopathy

McMillin, M., Grant, S. M., Frampton, G. A., Petrescu, A. D., Kain, J., Williams, E., Haines, R., Canady, L., & DeMorrow, S. (2018) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2018.02.008 · Cited by 38 · see citing works

Lipid efflux mechanisms, relation to disease and potential therapeutic aspects

Castaño, D., Rattanasopa, C., Monteiro-Cardoso, V. F., Corlianò, M., Liu, Y., Zhong, A., Rusu, M., Liehn, E. A., & Singaraja, R. R. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.04.013 · Cited by 37 · see citing works

Novel therapeutic strategies for Alzheimer’s disease targeting brain cholesterol homeostasis

Samant, N. P., & Gupta, G. L. (2020) · European Journal of Neuroscience · doi:10.1111/ejn.14949 · Cited by 36 · see citing works

Simvastatin impairs hippocampal synaptic plasticity and cognitive function in mice

Guo, Y., Zou, G., Qi, K., Jin, J., Yao, L., Pan, Y., & Xiong, W. (2021) · Molecular Brain · doi:10.1186/s13041-021-00758-x · Cited by 37 · see citing works

Brain cholesterol homeostasis and its association with neurodegenerative diseases

Gao, Y., Ye, S., Tang, Y., Tong, W., & Sun, S. (2023) · Neurochemistry International · doi:10.1016/j.neuint.2023.105635 · Cited by 38 · see citing works

Cholesterol Metabolism in Neurodegenerative Diseases: Molecular Mechanisms and Therapeutic Targets

Dai, L., Zou, L. B., Meng, L., Qiang, G., Yan, M., & Zhang, Z. (2021) · Molecular Neurobiology · doi:10.1007/s12035-020-02232-6 · Cited by 195 · see citing works

Cholesterol metabolism and homeostasis in the brain

Zhang, J., & Liu, Q. (2015) · Protein &amp; Cell · doi:10.1007/s13238-014-0131-3 · Cited by 686 · see citing works

Navigating the cholesterol maze: Key insights on use of statins in neurodegenerative disorders

Kuan, J. H., Raghavan, R., Koh, D. L. W., Tan, W. Y., Iezhitsa, I. N., & Agarwal, R. (2026) · Neuroprotection/Neuroprotection (Chichester, England. Print) · doi:10.1002/nep3.70026 · Cited by 2 · see citing works

Cholesterol Metabolism in Neurodegenerative Diseases

He, K., Zhao, Z., Zhang, J., Li, D., Wang, S., & Liu, Q. (2024) · Antioxidants and Redox Signaling · doi:10.1089/ars.2024.0674 · Cited by 28 · see citing works